Non-alcoholic and alcoholic fatty liver disease - Two diseases of affluence associated with the metabolic syndrome and type 2 Diabetes: The FIN-D2D survey

BMC Public Health

Volumn 10, Issue , 2010, Pages

  Kotronen, Anna ^a,b,c   Yki Järvinen, Hannele ^b   Männistö, Satu ^a   Saarikoski, Liisa ^a   Korpi Hyövälti, Eeva ^d   Oksa, Heikki ^e   Saltevo, Juha ^f   Saaristo, Timo ^e   Sundvall, Jouko ^a   Tuomilehto, Jaakko ^b   Peltonen, Markku ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c MINERVA FOUNDATION INSTITUTE FOR MEDICAL RESEARCH   (Finland)

^d SOUTH OSTROBOTHNIA CENTRAL HOSPITAL   (Finland)

^e TAMPERE UNIVERSITY HOSPITAL   (Finland)

^f Central Finland Central Hospital   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOLIC FATTY LIVER; ARTICLE; COMORBIDITY; FATTY LIVER; FEMALE; FINLAND; GLUCOSE INTOLERANCE; HUMAN; INDIA; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE;

ADULT; COMORBIDITY; DIABETES MELLITUS, TYPE 2; FATTY LIVER; FATTY LIVER, ALCOHOLIC; FEMALE; FINLAND; GLUCOSE INTOLERANCE; HUMANS; INDIA; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREVALENCE;

EID: 77951954751     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-10-237     Document Type: Article

References (30)

1. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. BA Neuschwander-Tetri SH Caldwell, Hepatology 2003 37 5 1202 1219 10.1053/jhep.2003.50193 12717402
2. The prevalence and etiology of elevated aminotransferase levels in the United States. JM Clark FL Brancati AM Diehl, Am J Gastroenterol 2003 98 5 960 967 10.1111/j.1572-0241.2003.07486.x 12809815
3. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. LS Szczepaniak P Nurenberg D Leonard JD Browning JS Reingold S Grundy HH Hobbs RL Dobbins, Am J Physiol Endocrinol Metab 2005 288 2 462 8 10.1152/ajpendo.00064.2004 15339742
4. The epidemiology of nonalcoholic fatty liver disease in adults. JM Clark, J Clin Gastroenterol 2006 40 3 Suppl 1 5 10 16540768
5. Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course. H Cortez-Pinto ME Camilo, Best Pract Res Clin Gastroenterol 2004 18 6 1089 1104 15561640
6. Long term prognosis of fatty liver: risk of chronic liver disease and death. S Dam-Larsen M Franzmann IB Andersen P Christoffersen LB Jensen TI Sorensen U Becker F Bendtsen, Gut 2004 53 5 750 755 10.1136/gut.2003.019984 15082596
7. Prognosis of patients with a diagnosis of fatty liver - a registry-based cohort study. P Jepsen H Vilstrup L Mellemkjaer AM Thulstrup JH Olsen JA Baron HT Sorensen, Hepatogastroenterology 2003 50 54 2101 2104 14696473 (Pubitemid 37468003)
8. Biochemical markers of alcohol abuse. PC Sharpe R McBride GP Archbold, QJM 1996 89 2 137 144 8729555
9. Elevated serum GGT concentrations predict reduced insulin sensitivity and increased intrahepatic lipids. C Thamer O Tschritter M Haap F Shirkavand J Machann A Fritsche F Schick H Haring M Stumvoll, Horm Metab Res 2005 37 4 246 251 10.1055/s-2005-861411 15952086
10. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. WHO MONICA Project Principal Investigators. Anonymous, J Clin Epidemiol 1988 41 2 105 114 10.1016/0895-4356(88)90084-4 3335877
11. Liver fat in the metabolic syndrome. A Kotronen J Westerbacka R Bergholm KH Pietilainen H Yki-Jarvinen, J Clin Endocrinol Metab 2007 92 9 3490 3497 10.1210/jc.2007-0482 17595248
12. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. WHO Consultation, World Health Organization 1999 Report No 99.2(Part 1)
13. The metabolic syndrome - a new worldwide definition. KG Alberti P Zimmet J Shaw IDF Epidemiology Task Force Consensus Group, Lancet 2005 366 9491 1059 1062 10.1016/S0140-6736(05)67402-8 16182882 (Pubitemid 41338752)
14. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. WT Friedewald RI Levy DS Fredrickson, Clin Chem 1972 18 6 499 502 4337382
15. StataCorp: Stata Statistical Software. Anonymous, Release 9.0 College Station, TX: StataCorp LP 2005
16. Updated definitions of healthy ranges for serum alanine aminotransferase levels. D Prati E Taioli A Zanella E Della Torre S Butelli E Del Vecchio L Vianello F Zanuso F Mozzi S Milani D Conte M Colombo G Sirchia, Ann Intern Med 2002 137 1 1 10 12093239
17. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. G Bedogni L Miglioli F Masutti C Tiribelli G Marchesini S Bellentani, Hepatology 2005 42 1 44 52 10.1002/hep.20734 15895401
18. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. CA Matteoni ZM Younossi T Gramlich N Boparai YC Liu AJ McCullough, Gastroenterology 1999 116 6 1413 1419 10.1016/S0016-5085(99)70506-8 10348825
19. Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. E Bugianesi U Pagotto R Manini E Vanni A Gastaldelli R de Iasio E Gentilcore S Natale M Cassader M Rizzetto R Pasquali G Marchesini, J Clin Endocrinol Metab 2005 90 6 3498 3504 10.1210/jc.2004-2240 15797948
20. Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic Fatty liver disease. Z Yesilova H Yaman C Oktenli A Ozcan A Uygun E Cakir SY Sanisoglu A Erdil Y Ates M Aslan U Musabak MK Erbil N Karaeren K Dagalp, Am J Gastroenterol 2005 100 4 850 855 10.1111/j.1572-0241.2005.41500.x 15784031
21. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. D Sorbi J Boynton KD Lindor, Am J Gastroenterol 1999 94 4 1018 1022 10.1111/j.1572-0241.1999.01006.x 10201476
22. Metabolic syndrome pandemic. SM Grundy, Arterioscler Thromb Vasc Biol 2008 28 4 629 636 10.1161/ATVBAHA.107.151092 18174459
23. Ethanol enhances de novo synthesis of high density lipoprotein cholesterol. JE Cluette JJ Mulligan R Noring K Doyle J Hojnacki, Proc Soc Exp Biol Med 1984 176 4 508 511 6463061
24. Effects of alcohol consumption on serum lipoprotein-lipid and apolipoprotein concentrations. Results from an intervention study in healthy subjects. JR Masarei IB Puddey IL Rouse WJ Lynch R Vandongen LJ Beilin, Atherosclerosis 1986 60 1 79 87 10.1016/0021-9150(86)90090-0 3707675
25. Alcohol intake and variations in blood pressure by day of examination. G Wannamethee AG Shaper, J Hum Hypertens 1991 5 2 59 67 1677046
26. Fatty liver: a novel component of the metabolic syndrome. A Kotronen H Yki-Jarvinen, Arterioscler Thromb Vasc Biol 2008 28 1 27 38 10.1161/ATVBAHA.107. 147538 17690317
27. Association of nonalcoholic fatty liver disease with insulin resistance: is OGTT indicated in nonalcoholic fatty liver disease? M Sargin O Uygur-Bayramicli H Sargin E Orbay A Yayla, J Clin Gastroenterol 2003 37 5 399 402 10.1097/00004836-200311000-00010 14564188
28. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. P Angulo JM Hui G Marchesini E Bugianesi J George GC Farrell F Enders S Saksena AD Burt JP Bida K Lindor SO Sanderson M Lenzi LA Adams J Kench TM Therneau CP Day, Hepatology 2007 45 4 846 854 10.1002/hep.21496 17393509
29. National type 2 diabetes prevention programme in Finland: FIN-D2D. T Saaristo M Peltonen S Keinanen-Kiukaanniemi M Vanhala J Saltevo L Niskanen H Oksa E Korpi-Hyovalti J Tuomilehto FIN-D2D Study Group, Int J Circumpolar Health 2007 66 2 101 112 17515250
30. High prevalence of obesity, central obesity and abnormal glucose tolerance in the middle-aged Finnish population. TE Saaristo NC Barengo E Korpi-Hyovalti H Oksa H Puolijoki JT Saltevo M Vanhala J Sundvall L Saarikoski M Peltonen J Tuomilehto, BMC Public Health 2008 8 423 10.1186/1471-2458-8-423 19113993